Medtronic
Quarterly Financials
| Values in thousands | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
Revenue | $9,807,000 | $9,018,000 | $8,961,000 | $8,578,000 |
Gross Profit | 7,441,000 | 5,851,000 | 5,405,000 | 4,946,000 |
EBITDA | 2,637,000 | 2,490,000 | 2,366,000 | 2,225,000 |
EBIT | 2,012,000 | 1,585,000 | 1,777,000 | 1,477,000 |
Net Income | 1,243,000 | 1,143,000 | 1,374,000 | 1,040,000 |
Net Change In Cash | 9,807,000 | 9,018,000 | 8,961,000 | 8,578,000 |
Free Cash Flow | 2,085,000 | 2,300,000 | 457,000 | 584,000 |
Cash | 1,949,000 | 1,147,000 | 1,282,000 | 1,273,000 |
Basic Shares | 1,288,100 | 1,288,200 | 1,287,500 | 1,287,100 |
Annual Financials
| Values in thousands | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
Revenue | $36,364,000 | $33,537,000 | $32,364,000 | $31,227,000 |
Gross Profit | 23,643,000 | 21,905,000 | 21,148,000 | 20,508,000 |
EBITDA | 9,809,000 | 9,218,000 | 8,203,000 | 8,697,000 |
EBIT | 6,851,000 | 6,357,000 | 5,556,000 | 6,000,000 |
Net Income | 4,800,000 | 4,662,000 | 3,676,000 | 3,758,000 |
Net Change In Cash | 36,364,000 | 33,537,000 | 32,364,000 | 31,227,000 |
Cost of Revenue | -2,414,000 | |||
Free Cash Flow | 5,426,000 | 5,185,000 | 5,200,000 | 4,580,000 |
Cash | 1,949,000 | 2,218,000 | 1,284,000 | 1,543,000 |
Basic Shares | 1,288,100 | 1,289,900 | 1,330,200 | 1,332,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-04-30 | $1.55 |
2026-01-31 | $1.36 |
2025-10-31 | $1.36 |
2025-07-31 | $1.26 |